Urgent treatment solutions are needed for children, adolescents and adults with mental health conditions. Despite the government committing to spending 8.9% of all NHS funding on mental health treatment last year, the pipeline to build new facilities and train new staff will take years and, on their own, are insufficient to meet demand.
A suite of online therapies, developed and clinically validated by expert teams at the University of Oxford’s Experimental Psychology and Psychiatry Departments, is now available to help close this gap in care, and tackle anxiety disorders and mental health conditions across all age groups from children through to adolescents and adults. Patients work through a series of online modules with the brief support of a therapist through short phone or video calls and messages.
Randomised clinical trials by the University of Oxford team have demonstrated the impact of all four of the online platforms. Excellent results led to a new commercial licence partnership negotiated between Oxford University Innovation and Koa Health, a company well placed to leverage this cutting-edge technology and research. Koa Health looks forward to making the programmes available to patients across many NHS services, beginning in West Sussex, Oxfordshire, Buckinghamshire, Leicestershire, Bradford, North Tyneside, and London.
more recommended stories
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance — University of Oxford, Medical Sciences DivisionThe IOI Synergy Grants scheme is.
The Translational Research Immunology Group (TRIG) celebrates huge success at International Congress of The Transplantation SocietyNora Atallah and Professor Fadi Issa.
Leave a Comment